A new masking technology could expand the therapeutic potential of antibodies for treating Parkinson's disease
Peer-Reviewed Publication
Updates every hour. Last Updated: 28-Oct-2026 21:17 ET (29-Oct-2026 01:17 GMT/UTC)
A new technology that could overcome these barriers, enabling antibodies to reach the most important targets, those located inside the cell itself.
In a 50-year follow-up study, men with a low cardiovascular risk in their 40s retained their functional capacity, happiness and quality of life better than others as they aged.
Scientists from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and St. Jude Children’s Research Hospital in the United States have discovered how blood cells release an important signalling fat called sphingosine-1-phosphate, or S1P, into the bloodstream.
Researchers at the University of Osaka discovered FoeAB, a previously unknown bacterial pump that exports the antibiotic fosfomycin. By combining transport experiments with cryo-electron microscopy, the team revealed how the protein recognizes and moves the drug across the cell membrane. The findings expand understanding of antibiotic efflux in Gram-positive bacteria and could support new strategies to counter drug resistance and improve treatment of bacterial infections.